Research › Fact Sheets › HUM

HUMANA INC

LISTEDNYSE

SYMBOLHUM

SIC6324

STATE OF INC.DE

FISCAL YEAR ENDSDecember 31

CIK49071

HOSPITAL & MEDICAL SERVICE PLANS · LARGE ACCELERATED FILER · 10 FISCAL YEARS OF SEC XBRL DATA, 2016–2025

Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.

CAPITALIZATION 12/31/25

($ millions)	Amount	%
Total debt	12,369	41.2
Stockholders' equity	17,657	58.8
Total capitalization	30,026	100.0

120,061,500 shares outstanding at 31 March 2026 (cover page of the 10-Q filed 29 April 2026).

LONG-TERM DEBT 12/31/25

($ millions)	Amount
Long-term debt, noncurrent	12,369
Current maturities	0

CAPITAL STOCK 12/31/25

Common shares authorized	300,000,000
Common shares issued	198,719,321
Treasury shares	78,128,009
Par or stated value per share ($)	0.1667
Preferred stock ($ millions)	0
Outstanding at 3/31/26	120,061,500

DIVIDENDS DECLARED/PAID

Fiscal year	Per share $	Payout %
2025	3.54	36.0
2024	3.54	35.5
2023	3.44	17.2
2022	3.06	13.9
2021	2.73	12.0

HISTORY AND BUSINESS

HISTORY: Incorporated in Delaware.

BUSINESS: Classified by the SEC under Standard Industrial Classification 6324, Hospital & Medical Service Plans. Large accelerated filer. Principal executive office: 101 E. Main Street, Louisville, KY. Fiscal year ends December 31. For a description of the business, see Item 1 of the latest 10-K.

CONSOLIDATED INCOME ACCOUNT, YEARS ENDED

($ millions)	12/31/25	12/31/24	12/31/23
Premiums earned	122,825	112,104	101,272
Net investment income	1,006	1,226	1,069
Total revenues	129,664	117,761	106,374
Benefits, losses and expenses	126,960	115,199	102,361
Income before income taxes	1,438	1,620	3,325
Income taxes	250	413	836
Net income	1,188	1,207	2,489
Earned per share, diluted ($)	9.84	9.98	20.00
Dividends per share ($)	3.54	3.54	3.44

CONSOLIDATED BALANCE SHEET

($ millions)	12/31/25	12/31/24
Cash and equivalents	4,200	2,221
Total assets	48,909	46,479
Policy liabilities and reserves	9,967	10,440
Total liabilities	31,172	30,034
Stockholders' equity	17,657	16,375

TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)

Fiscal year ended	Revenues	Oper. income	Net income	Net margin %	EPS diluted $	Div. per share $	Oper. cash flow	Total assets	Total liabilities	Total debt	Deposits	Stockholders' equity	ROE %	Debt / equity
12/31/25	129,664	2,704	1,188	0.9	9.84	3.54	921	48,909	31,172	12,369	–	17,657	6.7	0.70
12/31/24	117,761	2,562	1,207	1.0	9.98	3.54	2,966	46,479	30,034	11,721	–	16,375	7.4	0.72
12/31/23	106,374	4,013	2,489	2.3	20.00	3.44	3,981	47,065	30,747	11,656	–	16,262	15.3	0.72
12/31/22	92,870	3,800	2,806	3.0	22.08	3.06	4,587	43,055	27,685	11,126	–	15,311	18.3	0.73
12/31/21	83,064	3,148	2,933	3.5	22.67	2.73	2,262	44,358	28,255	12,494	–	16,080	18.2	0.78
12/31/20	77,155	4,986	3,367	4.4	25.31	2.43	5,639	34,969	21,241	6,660	–	13,728	24.5	0.49
12/31/19	64,888	3,192	2,707	4.2	20.10	2.15	5,284	29,074	17,037	5,666	–	12,037	22.5	0.47
12/31/18	56,912	3,100	1,683	3.0	12.16	1.90	2,173	25,413	15,252	7,763	–	10,161	16.6	0.76
12/31/17	53,767	4,262	2,448	4.6	16.81	1.49	4,051	27,178	17,336	4,920	–	9,842	24.9	0.50
12/31/16	54,379	1,741	614	1.1	4.07	1.16	1,936	25,396	14,711	4,092	–	10,685	5.7	0.38

Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; capital expenditure and free cash flow are not shown for banks and insurers, where they are not meaningful; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.

REGISTRANT:

HUMANA INC
CIK 49071 · EIN 61-0647538

PRINCIPAL OFFICE:

101 E. Main Street, Louisville, KY
Tel.: 5025801000

INCORPORATED:

Delaware

INDUSTRY (SEC SIC CODE):

6324 · Hospital & Medical Service Plans

FILER STATUS:

Large accelerated filer

LATEST ANNUAL REPORT:

10-K for period ended 12/31/25, filed 19 February 2026

RECENT FILINGS (ANNUAL REPORT REFERENCES BELOW):

10/13/26	8-K	period 10/13/26
10/9/26	8-K	period 10/9/26
9/1/26	8-K	period 9/1/26
7/29/26	10-Q	period 6/30/26
7/29/26	8-K	period 7/28/26
7/29/26	8-K	period 7/29/26
6/1/26	8-K	period 6/1/26
5/19/26	8-K	period 5/15/26

Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/19/26) · 10-K FY2024 (filed 2/20/25) · 10-K FY2023 (filed 2/15/24) · 10-K FY2022 (filed 2/16/23) · 10-K FY2021 (filed 2/17/22) · 10-K FY2020 (filed 2/18/21) · 10-K FY2019 (filed 2/20/20) · 10-K FY2018 (filed 2/21/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.